We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Transdermal Drug Delivery Company, Medherant, Have Raised £3.8 M in Funding

Product News   Dec 11, 2017 | Medherant

 
Transdermal Drug Delivery Company, Medherant, Have Raised £3.8 M in Funding
FURTHER INFORMATION
 
 
 

Related Product News

BD Completes Clinical Trial for BD Libertas™ Wearable Injector

Product News

BD has announced the completion of a 50-subject human clinical trial with the BD Libertas™ Wearable Injector.

READ MORE

Accelerating Neuroscience-focused Ion Channel Drug Discovery

Product News

Metrion and LifeArc have announced an extension of their neuroscience-focused ion channel drug discovery collaboration, following the success of the initial twelve-month agreement.

READ MORE

LEO Pharma Announces Agreement with Ubiquigent To Access Novel Compounds

Product News

Ubiquigent and LEO Pharma have announced that they have entered into an option agreement granting LEO Pharma access to two novel compounds.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE